February 2025
The U.S. behavioral health market size was calculated at USD 92.2 billion in 2024, to reach USD 96.9 billion in 2025 is expected to be worth USD 151.62 billion by 2034, expanding at a CAGR of 5.1% from 2024 to 2034.
Unlock Infinite Advantages: Subscribe to Annual Membership
Behavioral health refers to a mental health condition leading to stress, anxiety, and depression. Destructive behavior is mainly caused due to eating disorders, substance abuse, self-injury, and addiction. Some behavioral health disorders are present from childhood, such as ADHD or autism. All these conditions require early detection, prevention, and treatment. These disorders are treated through rehabilitation programs, including psychotherapy along with medications. Psychotherapy includes cognitive behavioral therapy, exposure therapy, parent education, social skills training, and family support services. Additionally, alternative therapies are available, such as brain stimulation therapy.
Artificial intelligence (AI) plays a vital role in transforming mental health services. AI and machine learning (ML) algorithms can screen large amounts of people to assess their mental health. This increases accuracy and precision, reducing manual errors. AI increases the accessibility of treatment care to patients by providing telehealth services. AI-based chatbots are utilized to offer advice and a line of communication for patients, helping them to cope with symptoms. AI-based sensors are integrated into wearables that can interpret body signals and provide real-time mental health status. AI and ML can also predict outcomes in patients receiving advanced rehabilitation therapy. AI can also be used to design personalized treatment for patients by monitoring their symptoms and reactions to treatment.
The major growth factor of the U.S. behavioral market is favorable government support to promote behavioral health treatment. The U.S. government formed “The Substance Abuse and Mental Health Services Administration (SAMHSA)” to look after behavioral health in the U.S. SAMHSA released an updated “National Behavioral Health Crisis Care Guidance” policy in 2025 for state, territory, tribal, and local governments and others to understand, implement, and sustain effective behavioral health crisis services and guide practitioners about the same. Additionally, The White House committed a national strategy for addressing mental illness and substance abuse disorders in 2024. The increasing public-private partnerships and collaborations to promote mental health care in the U.S. raise awareness among the general public.
Even after the Mental Health Parity and Addiction Equity Act (MHPAEA) was passed in 2008, many Americans with insurance still do not have access to comparable behavioral health coverage. The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health insurers and group health plans that cover behavioral health services to provide the same level of benefits for mental health and/or substance use treatment and services as they do for medical and surgical care, but it does not require that behavioral health treatments be covered. Furthermore, even though the Department of Health and Human Services (HHS) produced an action plan for the law's implementation in April 2018 as required by Congress, the provisions' strict enforcement has fallen short.
Access to mental health services may be restricted by the coverage restrictions and limitations in the Medicaid and Medicare programs. Even though Medicaid requires states to fund medically necessary mental health care, states have some discretion in determining medical necessity, which can result in inequities in coverage. States may also provide particular services as optional perks (e.g., rehabilitation, therapy, medication management, and peer support). State-by-state variations in these optional services' accessibility notwithstanding, many are essential for improved recovery and health. Even though IMDs can support adolescent recovery, treatment at institutes of mental illness (IMDs) is an optional service covering children and adolescents with behavioral health difficulties up to the age of 21. Medicare also restricts access to some behavioral health treatments by capping lifetime payments for inpatient mental health treatment at 190 days. This restricts recipients' access to life-saving care, especially for individuals with severe mental illnesses.
Historically, behavioral health treatment has been provided by state mental health organizations, which are chronically underfunded. Similar underpayments apply to providers in the continuum of mental health care under conventional fee-for-service payment models. Important features of behavioral health treatment, such as managing care remotely or coordinating care across clinicians and locations, are rarely covered by fee-for-service payment models (referrals, case management, etc.).
Poor reimbursement rates further impede access to behavioral health services. A recent study found that reimbursement for mental health doctors is still 20% lower than for primary care doctors. The reimbursement issues are a reflection of the undervaluing of mental health services, which usually require more investigation and effort than procedural procedures.
The use of outcome measures is constrained despite a requirement for measurement-based behavioral healthcare on a national scale due to a lack of provider adoption and technological infrastructure to measure and report findings on a big scale. Thus, only about 50% of Americans who suffer from mental diseases obtain care. Even then, there is no measurement of quality, and when there is, there is cause for concern.
Not just policymakers and healthcare professionals, but new approaches are required to address these problems during and after the pandemic. Payers who have been criticized or questioned for their impact on behavioral healthcare access now have a chance to change the future. Payers have traditionally prioritized behavioral health cost reduction, typically working with carve-out companies, which has contributed to the existing system's fragmentation and accessibility issues.
To better the accessibility, effectiveness, and quality of mental health care, Blue Shield of North Carolina (Blue Cross NC) and Blue Cross are currently in the second year of a long-term strategy. The five activities mentioned in this essay include eliminating the integrating care, carve-out, quantifying effect, deploying point solutions at scale, and increasing value-based reimbursement. Although this plan was put in place before COVID-19, it provided a strong foundation that allowed us to quickly change course and accommodate the additional behavioral health aspects of the pandemic. This example shows how payment reform might encourage the development of an adaptable and responsive behavioral health system, especially during periods of high demand.
In, outpatient counseling held the biggest market share, and it is anticipated that this pattern will hold throughout the forecast period. The most common form of treatment for many mental health conditions is outpatient care since it is less expensive, more accommodating of patients' needs and schedules, and has a larger provider pool. Only when ongoing support is not necessary and it is healthy for the patient to remain in their environment to deal with stressors and learn to manage with professional aid can outpatient treatment be employed. This is typically the greatest option for persons who have eating disorders, depression, or anxiety.
The internet has created new opportunities for projects in rehabilitation. Technology has given people a new therapeutic alternative to help them overcome their addictions, although in-person counseling and treatment were formerly the only options to do so. Through group therapy sessions held over Zoom or Google Meet, individual online face-to-face chats, and online video chat, patients and their families have simple access to licensed addiction professionals and their network of supporters. Both the patient's quality of life and their chances of recovery are enhanced by this increased accessibility. If patients can obtain information online and avoid having to travel to and from an outpatient treatment facility, they will be more inclined to continue with therapy.
The demand for home-based treatment services is predicted to increase during the projection period, which will result in a decline in the percentage of inpatient hospital treatment, which was 22.0% in 2020. Before the implementation of COVID-19, the majority of payers (including the federal government) only provided coverage for home-based modalities (such as direct-to-consumer and mobile applications) for a small number of conditions that frequently required the coverage of physical comorbidities. In the case of a patient who also has a chronic ailment like diabetes, this may, for instance, just pay telemedicine treatment for substance use disorder. The phenomenal growth of home delivery of telehealth for virtually all diseases has significantly enhanced access to care in emergencies COVID-19 advice and payer policy.
In, anxiety and depressive disorders held the highest market share because of the high incidence of COVID-19, which led to lockdowns and social withdrawal.
Other potential causes of anxiety and depression include negative life events, societal pressure, and lack of access to mental health resources. The increasing incidences of anxiety and depression and growing research and development activities for their treatment boost the segment’s growth. According to the American Psychiatry Association, around 43% of adults were reported to feel more anxious in 2024 compared to 37% in 2023. This rising trend potentiates the need for early detection and treatment.
By disorder type, the substance abuse disorder segment is projected to expand rapidly in the market in the coming years. Substance abuse disorder is mainly caused by over-consumption of alcohol, opioids, and marijuana. About 17.82% of adults, i.e. over 45 million people in the U.S. had a substance use disorder in 2024. The increasing incidences of substance abuse disorder augment the segment’s growth. The rise in rehabilitation centers and growing awareness also potentiate the segment’s growth.
The largest market share held by outpatient clinics in 2020 was 36.9%. Since the majority of patients are diagnosed with mild to moderate symptoms and do not necessarily need to be admitted to hospitals, the sector is anticipated to continue to be the largest.
Mental health professionals have generally operated independently from primary care doctors in clinical care. A one-stop shop can assist ensure that patients obtain treatment sooner and, as a result, cut costs for both patients and providers. This is done by better integrating behavioral health and basic care. For instance, Genoa Healthcare integrates telepsychiatry, medical management, and outpatient mental health care. Psychiatrists now have access to more information that is necessary for accurate patient diagnosis and treatment. Genoa's telepsychiatry services created a patient-centered model and offered a solution for many adults and families who couldn't access mental healthcare.
US Behavioral Health Post-COVID-19 Market Size and Estimations, By End-User, 2021-2027 (USD Billion)
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | CAGR (2021-27) | |
Outpatient Clinics | 35.81 | 37.99 | 40.17 | 42.34 | 44.49 | 46.59 | 48.63 | 5.23% |
Hospitals | 24.32 | 25.40 | 26.43 | 27.41 | 28.32 | 29.16 | 29.91 | 3.51% |
Rehabilitation Centers | 21.32 | 22.37 | 23.38 | 24.36 | 25.29 | 26.17 | 26.99 | 4.00% |
Homecare Setting | 15.56 | 17.25 | 19.04 | 20.90 | 22.84 | 24.84 | 26.90 | 9.55% |
Total | 97.01 | 103.01 | 109.02 | 115.01 | 120.94 | 126.76 | 132.42 | 5.32% |
Due to patient preference, it is anticipated that demand for homecare settings would increase during the projected period. Additionally, throughout the forecast period, the segment for homecare settings is anticipated to rise as more doctors and patients use telehealth solutions in this medical field.
The rise of home care is also being aided by the constantly developing technology that lets patients remain in their own homes. The effectiveness and security of home care can be increased with the aid of internet-based applications, software, and equipment. These technologies include but are not limited to, patient portals, online support groups, caregiver education, and training materials, mobile apps for appointment scheduling and reminders, improvements in telemedicine/telehealth, wearable sensors that remotely monitor patients, personal response systems that can be used to alert a call center when a patient falls, and automated medication dispensing systems. This segment's growth is anticipated to be accelerated by the growing adoption of telehealth.
One in four Medicare users suffers from a mental disorder. The prevalence of mental illness appears to be slightly higher among Medicare enrollees in traditional Medicare than in Medicare Advantage managed care plans, although comparisons are challenging due to varied data sources and measures used in different research. Traditional Medicare beneficiaries are more likely to suffer from a severe mental illness that leaves them significantly disabled, such as schizophrenia, bipolar disorder, or major depressive disorder.
Over 112 million Americans reside in areas with a dearth of mental healthcare providers, and by 2025, shortages of counselors, psychiatrists, mental health social workers, clinical & counseling psychologists, and other specialized professionals are expected to get worse, according to experts. Rural areas experience a particularly acute shortage of mental health providers, although the prevalence of mental disease among beneficiaries is comparable between rural and urban areas.
The rising incidences of mental health disorders are the major growth factor of the market. Anxiety disorders are the most common type of mental health disorder in the U.S., accounting for 19.1% of all cases, followed by major depression, post-traumatic stress disorder, and bipolar disorder. The increasing number of behavioral health facilities in the U.S. contributes to market growth. There were around 15,424 Mental Health & Substance Abuse Clinics in the U.S., as of 2023. The growing awareness among the general public about behavioral health potentiates the market. Favorable government initiatives and increasing investments also augment the market. The U.S. government provided funding of $240 million to launch and expand mental health and substance use disorder services in more than 400 community health centers across the country.
Marketa Wills, MD, MBA, CEO and Medical Director of the American Psychiatric Association, commented that telehealth services; collaboration between medical societies, physicians and patients, and organizations; as well as access to information are the major factors that can increase access to mental care. She added that insurers must abide by the laws to ensure patients receive benefits from mental health services.
By Service Type
By Disorder Type
By End-User
February 2025
February 2025
January 2025
December 2024